Effects of long-term glucocorticoid therapy on bronchoalveolar cells in adult patients with bronchial asthma

Yoshiro Tanizaki, Hikaru Kitani, Morihiro Okazaki, Takashi Mifune, Fumihiro Mitsunobu, Ikuro Kimura

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of long-term glucocorticoid therapy on airway inflammation were examined in 84 asthma patients. The proportion of lymphocytes in bronchoalveolar lavage (BAL) fluid was significantly decreased in patients with steroid-dependent intractable asthma (SDIA) compared to results in non-SDIA patients, while BAL neutrophils were significantly increased in SDIA patients compared to results in non-SDIA patients. Regarding age, in patients under the age of 69 (except those between 30 and 39), BAL lymphocyte number was significantly decreased in SDIA compared with non-SDIA subjects, and in patients between 50 and 69, BAL neutrophils were significantly increased in SDIA compared with non-SDIA subjects. The number of BAL lymphocytes was significantly lower in patients with serum cortisol levels of less than 5.0 μg/dl than in those with levels of more than 5.1 μg/dl. BAL lymphocyte number was also significantly lower in patients who had received glucocorticoid therapy for more than 6 years than in those who had received such therapy for 2 years. These results show that long-term glucocorticoid therapy decreases the number of lymphocytes and increases neutrophil numbers in the airways.

Original languageEnglish
Pages (from-to)309-318
Number of pages10
JournalJournal of Asthma
Volume30
Issue number4
DOIs
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Glucocorticoids
Asthma
Bronchoalveolar Lavage
Lymphocyte Count
Steroids
Neutrophils
Therapeutics
Lymphocytes
Bronchoalveolar Lavage Fluid
Hydrocortisone
Inflammation
Serum

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

Cite this

Effects of long-term glucocorticoid therapy on bronchoalveolar cells in adult patients with bronchial asthma. / Tanizaki, Yoshiro; Kitani, Hikaru; Okazaki, Morihiro; Mifune, Takashi; Mitsunobu, Fumihiro; Kimura, Ikuro.

In: Journal of Asthma, Vol. 30, No. 4, 1993, p. 309-318.

Research output: Contribution to journalArticle

Tanizaki, Yoshiro ; Kitani, Hikaru ; Okazaki, Morihiro ; Mifune, Takashi ; Mitsunobu, Fumihiro ; Kimura, Ikuro. / Effects of long-term glucocorticoid therapy on bronchoalveolar cells in adult patients with bronchial asthma. In: Journal of Asthma. 1993 ; Vol. 30, No. 4. pp. 309-318.
@article{f3fde0d161e64e53b46be9bfc3a189e9,
title = "Effects of long-term glucocorticoid therapy on bronchoalveolar cells in adult patients with bronchial asthma",
abstract = "The effects of long-term glucocorticoid therapy on airway inflammation were examined in 84 asthma patients. The proportion of lymphocytes in bronchoalveolar lavage (BAL) fluid was significantly decreased in patients with steroid-dependent intractable asthma (SDIA) compared to results in non-SDIA patients, while BAL neutrophils were significantly increased in SDIA patients compared to results in non-SDIA patients. Regarding age, in patients under the age of 69 (except those between 30 and 39), BAL lymphocyte number was significantly decreased in SDIA compared with non-SDIA subjects, and in patients between 50 and 69, BAL neutrophils were significantly increased in SDIA compared with non-SDIA subjects. The number of BAL lymphocytes was significantly lower in patients with serum cortisol levels of less than 5.0 μg/dl than in those with levels of more than 5.1 μg/dl. BAL lymphocyte number was also significantly lower in patients who had received glucocorticoid therapy for more than 6 years than in those who had received such therapy for 2 years. These results show that long-term glucocorticoid therapy decreases the number of lymphocytes and increases neutrophil numbers in the airways.",
author = "Yoshiro Tanizaki and Hikaru Kitani and Morihiro Okazaki and Takashi Mifune and Fumihiro Mitsunobu and Ikuro Kimura",
year = "1993",
doi = "10.3109/02770909309054531",
language = "English",
volume = "30",
pages = "309--318",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Effects of long-term glucocorticoid therapy on bronchoalveolar cells in adult patients with bronchial asthma

AU - Tanizaki, Yoshiro

AU - Kitani, Hikaru

AU - Okazaki, Morihiro

AU - Mifune, Takashi

AU - Mitsunobu, Fumihiro

AU - Kimura, Ikuro

PY - 1993

Y1 - 1993

N2 - The effects of long-term glucocorticoid therapy on airway inflammation were examined in 84 asthma patients. The proportion of lymphocytes in bronchoalveolar lavage (BAL) fluid was significantly decreased in patients with steroid-dependent intractable asthma (SDIA) compared to results in non-SDIA patients, while BAL neutrophils were significantly increased in SDIA patients compared to results in non-SDIA patients. Regarding age, in patients under the age of 69 (except those between 30 and 39), BAL lymphocyte number was significantly decreased in SDIA compared with non-SDIA subjects, and in patients between 50 and 69, BAL neutrophils were significantly increased in SDIA compared with non-SDIA subjects. The number of BAL lymphocytes was significantly lower in patients with serum cortisol levels of less than 5.0 μg/dl than in those with levels of more than 5.1 μg/dl. BAL lymphocyte number was also significantly lower in patients who had received glucocorticoid therapy for more than 6 years than in those who had received such therapy for 2 years. These results show that long-term glucocorticoid therapy decreases the number of lymphocytes and increases neutrophil numbers in the airways.

AB - The effects of long-term glucocorticoid therapy on airway inflammation were examined in 84 asthma patients. The proportion of lymphocytes in bronchoalveolar lavage (BAL) fluid was significantly decreased in patients with steroid-dependent intractable asthma (SDIA) compared to results in non-SDIA patients, while BAL neutrophils were significantly increased in SDIA patients compared to results in non-SDIA patients. Regarding age, in patients under the age of 69 (except those between 30 and 39), BAL lymphocyte number was significantly decreased in SDIA compared with non-SDIA subjects, and in patients between 50 and 69, BAL neutrophils were significantly increased in SDIA compared with non-SDIA subjects. The number of BAL lymphocytes was significantly lower in patients with serum cortisol levels of less than 5.0 μg/dl than in those with levels of more than 5.1 μg/dl. BAL lymphocyte number was also significantly lower in patients who had received glucocorticoid therapy for more than 6 years than in those who had received such therapy for 2 years. These results show that long-term glucocorticoid therapy decreases the number of lymphocytes and increases neutrophil numbers in the airways.

UR - http://www.scopus.com/inward/record.url?scp=0027240662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027240662&partnerID=8YFLogxK

U2 - 10.3109/02770909309054531

DO - 10.3109/02770909309054531

M3 - Article

C2 - 8331042

AN - SCOPUS:0027240662

VL - 30

SP - 309

EP - 318

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 4

ER -